CENTRAL RETINAL ARTERY OCCLUSION
Clinical trials for CENTRAL RETINAL ARTERY OCCLUSION explained in plain language.
Never miss a new study
Get alerted when new CENTRAL RETINAL ARTERY OCCLUSION trials appear
Sign up with your email to follow new studies for CENTRAL RETINAL ARTERY OCCLUSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye injection shows promise for sudden blindness
Disease control CompletedThis study tested a new drug called KUS121, given as an eye injection, for people who suddenly lost vision due to a blocked artery in the eye (central retinal artery occlusion). The goal was to see if it could safely improve vision compared to a sham procedure. The study included…
Matched conditions: CENTRAL RETINAL ARTERY OCCLUSION
Phase: PHASE2 • Sponsor: Kyoto Drug Discovery and Development Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 06:20 UTC
-
Clot-Busting drug shows promise for sudden blindness in eye artery blockage
Disease control CompletedThis study tested whether a clot-dissolving medicine called tenecteplase can restore vision in people who suddenly lose sight due to a blocked artery in the eye. 81 adults with central retinal artery occlusion received either tenecteplase or a placebo within 4.5 hours of symptoms…
Matched conditions: CENTRAL RETINAL ARTERY OCCLUSION
Phase: PHASE3 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated May 06, 2026 16:14 UTC